Drug
MVT-5873 clinical trials
Also written MVT-5873 and HuMab-5B1.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
BioNTech Research & Development, Inc. (2) · National Cancer Institute (NCI) (1) · BioNTech SE (1)
Often tested with
Tested in the same studies.
MVT-1075 (1)
Studies
Open first, then newest update. How each study uses MVT-5873 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic AdenocarcinomaTerminatedPhase 1/2BioNTech SENCT06069778Written as BNT321 0.5 mg/kg
- Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as RadioimmunotherapyTerminatedPhase 1BioNTech Research & Development, Inc.NCT03118349Written as MVT-5873
- Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal CancersCompletedPhase 2National Cancer Institute (NCI)NCT03801915Written as MVT-5873
- Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1TerminatedPhase 1BioNTech Research & Development, Inc.NCT02687230Written as MVT-5873
Given in every arm · 2 — MVT-5873 is usual care beside what is tested
- Study of a New Technique for Imaging Pancreatic CancerCompletedPhase 1Memorial Sloan Kettering Cancer CenterNCT04883775Written as MVT-5873
- Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive MalignanciesTerminatedPhase 1BioNTech Research & Development, Inc.NCT02672917Written as MVT-5873
Codes
What other systems call MVT-5873 · ClinicalTrials.gg INT017059
- UNII (FDA) KEX1QY18OHMVT-5873One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | KEX1QY18OH | MVT-5873 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.